Primary Care Clinics in El Portal, FL Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Visions Healthcare - El Portal Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8642 Ne 2nd Ave, El Portal, FL 33138 Phone: 305-751-7301 |
One Health Medical Center Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 211 Ne 89th St, El Portal, FL 33138 Phone: 305-882-9343 |
Midland Medical - Miami Shores, Inc. Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 8642 Ne 2nd Ave, El Portal, FL 33138 Phone: 305-751-9677 Fax: 305-899-7120 |
Midtown Health Center Llc Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Ne 89th St, El Portal, FL 33138 Phone: 786-552-7800 |
News Archive
Study explores whether alcohol consumption can have an effect on arthritis
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.
Medicare debate highlights competing views among young and old
The future of Medicare continues to be a hot topic in politics. The New York Times examines how the current debate over revamping the program is playing out among different age groups. And on Capitol Hill Friday, two Democratic senators urged that Medicare spending be debated independently from the current negotiations on raising the federal debt ceiling. Republicans quickly challenged that view.
Study shows how acceptance is key to living well with advanced cancer
A qualitative study of 22 cancer patients shows how acceptance is key to living as well as possible, although it requires time and is a process with ups and downs. Led by the University of Navarre, this research emphasizes the importance of focusing on life rather than on the disease.
Eleven Biotherapeutics announces first pivotal Phase 3 clinical study of EBI-005 for treatment of DED
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).
Novexel commences comparative study of NXL103 to oral linezolid
Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed to assess the safety and efficacy of NXL103 in comparison to oral linezolid.
› Verified 5 days ago